Human Fas Ligand/TNFSF6 Quantikine ELISA Kit

Product Details

Summary
Reactivity HuSpecies Glossary
Applications ELISA
Conjugate
HRP

Order Details

Human Fas Ligand/TNFSF6 Quantikine ELISA Kit Summary

Background
The Quantikine® Human Fas Ligand/TNFSF6 Immunoassay is a 4.5 hour solid-phase ELISA designed to measure human Fas Ligand in cell culture supernates, cell lysates, serum, and plasma. It contains CHO cell-expressed recombinant human Fas Ligand and has been shown to accurately quantitate the recombinant factor. Results obtained using natural human Fas Ligand showed linear curves tha...t were parallel to the standard curves obtained using the Quantikine® kit standards. These results indicate that this kit can be used to determine relative mass values for natural human Fas Ligand.
Show More
Specificity
Natural and recombinant human Fas Ligand.
Source
N/A
Inter-Assay
See PDF Datasheet for details
Intra-Assay
See PDF Datasheet for details
Spike Recovery
See PDF Datasheet for details
Sample Volume
See PDF Datasheet for details

Applications/Dilutions

Dilutions
  • ELISA
Application Notes
No significant interference observed with available related molecules.
Publications
Read Publications using DFL00B.

Packaging, Storage & Formulations

Storage
Store the unopened product at 2 - 8 °C. Do not use past expiration date.

Notes

This product is produced by and ships from R&D Systems, Inc., a Bio-Techne brand.

Alternate Names for Human Fas Ligand/TNFSF6 Quantikine ELISA Kit

  • apoptosis (APO-1) antigen ligand 1
  • Apoptosis antigen ligand
  • APT1LG1CD95L
  • APTL
  • CD178 antigen
  • CD178
  • CD95L
  • CD95-L
  • Fas antigen ligand
  • Fas ligand (TNF superfamily, member 6)
  • Fas Ligand
  • FASLCD95 ligand
  • FASLG
  • TNFSF6
  • TNFSF6FasL
  • tumor necrosis factor (ligand) superfamily, member 6
  • tumor necrosis factor ligand superfamily member 6

Background

Fas Ligand (FasL), also known as CD178, CD95L, or TNFSF6, is a transmembrane protein homotrimer that binds to Fas/CD95 and triggers apoptosis in the Fas-expressing cell. Fas Ligand also binds the soluble decoy receptor DcR3. It is expressed on activated Th1 cells, CD8+ cytotoxic T cells, and NK cells. A soluble form can be released which remains trimeric and retains the ability to bind Fas. Fas Ligand-induced apoptosis plays a central role in the development of immune tolerance and the maintance of immune privileged sites. Tumor cells can evade immune surveillance by upregulating Fas Ligand to kill tumor infiltrating lymphocytes. In gld mice, a Fas Ligand point mutation is the cause of severe lymphoproliferation and systemic autoimmunity.

Customers Who Viewed This Item Also Viewed...

NB120-13550
Species: Hu, Mu, Rt
Applications: ICC/IF, IHC, IHC-P, WB
NB100-56116
Species: Ma, Hu, Mu, Rt
Applications: Flow, ICC/IF, IHC, IHC-Fr, IHC-P, IP, Simple Western, WB
375-TL
Species: Hu
Applications: BA
NB100-56098
Species: Ca, Hu, Mu, Rt
Applications: IHC, IHC-P, IP, WB
202-IL
Species: Hu
Applications: BA
NB400-114
Species: Ch, Fe, Ha, Hu, Mu, Pl, Po, Pm, Rt
Applications: ICC/IF, IHC, IHC-P, IP, KD, WB
NB100-56104
Species: Ca, Hu, Mu, Rt
Applications: IHC, IHC-Fr, IHC-P, IP, WB
NBP1-19371
Species: Ca, Hu, Mu, Po, Rb, Rt
Applications: Dual ISH-IHC, Flow, ICC/IF, IHC, IHC-Fr, IHC-P, Simple Western, WB
NB100-56118
Species: Ca, Ma, Hu, Mu, Rt
Applications: Flow-IC, ICC/IF, IHC, IHC-Fr, IHC-P, IP, WB
7268-CT
Species: Hu
Applications: BA
NBP1-49045
Species: Mu, Rt
Applications: Cell Depl, CyTOF-ready, Flow, ICC/IF, IHC, IHC-Fr, IHC-P, IP, InhibTFunc
AF821
Species: Hu, Mu
Applications: WB
DFL00B
Species: Hu
Applications: ELISA
⚠ WARNING: This product can expose you to chemicals including N,N-Dimethylforamide, which is known to the State of California to cause cancer. For more information, go to www.P65Warnings.ca.gov.

Publications for Fas Ligand/TNFSF6 (DFL00B)(29)

We have publications tested in 2 confirmed species: Human, Mouse.


Filter By Application
All Applications
Filter By Species
Human
(28)
Mouse
(1)
All Species
Showing Publications 1 - 10 of 29. Show All 29 Publications.
Publications using DFL00B Applications Species
FS Thaler, B Bangol, M Biljecki, J Havla, AM Schumacher, T Kümpfel Possible link of genetic variants to autoimmunity in GAD-antibody-associated neurological disorders J. Neurol. Sci., 2020-04-29;413(0):116860. 2020-04-29 [PMID: 32388243] (Human) Human
A Masuda, Y Isobe, K Sugimoto, M Yoshimori, A Arai, N Komatsu Efficient recruitment of c-FLIPL to the death-inducing signaling complex leads to Fas resistance in natural killer-cell lymphoma Cancer Sci., 2020-01-31;111(3):807-816. 2020-01-31 [PMID: 31908105] (Human) Human
R Grzanka, A Damasiewic, A Kasperska- Tumor necrosis factor-alpha and Fas/Fas ligand signaling pathways in chronic spontaneous urticaria Allergy Asthma Clin Immunol, 2019-03-14;15(0):15. 2019-03-14 [PMID: 30911316] (Human) Human
Y Matsukiyo, H Nagai, T Matsui, Y Igarashi Host Immunological Effects of Partial Splenic Embolization in Patients with Liver Cirrhosis J Immunol Res, 2018-07-15;2018(0):1746391. 2018-07-15 [PMID: 30116748] (Human) Human
A Karowicz-B, U Kowalska-K, D Estemberg, A Sikora-Szu Evaluation of soluble concentration Fas and Fas ligand in maternal and cord blood 3rd trimester of pregnancy Ginekol. Pol., 2018-01-01;89(3):142-146. 2018-01-01 [PMID: 29664549] (Human) Human
Endotoxemia contributes to CD27+ memory B-cell apoptosis via enhanced sensitivity to Fas ligation in patients with Cirrhosis Sci Rep, 2016-11-18;6(0):36862. 2016-11-18 [PMID: 27857173] (Human) Human
Katz , Gil, Krummey , Scott M, Larsen , Sasha E, Stinson , Jeffrey, Snow , Andrew L SAP facilitates recruitment and activation of LCK at NTB-A receptors during restimulation-induced cell death. J Immunol, 2014-03-31;192(9):4202-9. 2014-03-31 [PMID: 24688028] (Human) Human
Liu Q, Tan Q, Zheng Y, Chen K, Qian C, Li N, Wang Q, Cao X Blockade of Fas signaling in breast cancer cells suppresses tumor growth and metastasis via disruption of Fas signaling-initiated cancer-related inflammation. J Biol Chem, 2014-03-13;289(16):11522-35. 2014-03-13 [PMID: 24627480] (Mouse) Mouse
Price S, Shaw P, Seitz A, Joshi G, Davis J, Niemela J, Perkins K, Hornung R, Folio L, Rosenberg P, Puck J, Hsu A, Lo B, Pittaluga S, Jaffe E, Fleisher T, Rao V, Lenardo M Natural history of autoimmune lymphoproliferative syndrome associated with FAS gene mutations. Blood, 2014-01-07;123(13):1989-99. 2014-01-07 [PMID: 24398331] (Human) Human
Beynon V, Quintana FJ, Weiner HL Activated Human CD4+CD45RO+ Memory T-Cells Indirectly Inhibit NLRP3 Inflammasome Activation through Downregulation of P2X7R Signalling. PLoS ONE, 2012-06-29;7(6):e39576. 2012-06-29 [PMID: 22768094] (Human) Human
Show All 29 Publications.

Reviews for Fas Ligand/TNFSF6 (DFL00B) (0)

There are no reviews for Fas Ligand/TNFSF6 (DFL00B). By submitting a review you will receive an Amazon e-Gift Card or Novus Product Discount.
  • Review with no image -- $10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen
  • Review with an image -- $25/€18/£15/$25 CAD/¥150 Yuan/¥2500 Yen

Product General Protocols

Find general support by application which include: protocols, troubleshooting, illustrated assays, videos and webinars.

FAQs for Fas Ligand/TNFSF6 (DFL00B) (0)

There are no specific FAQs related to this product. Read our general customer & technical service FAQs.

Additional Fas Ligand/TNFSF6 Products

Blogs on Fas Ligand/TNFSF6

There are no specific blogs for Fas Ligand/TNFSF6, but you can read our latest blog posts.

Customers Who Bought This Also Bought

Contact Information

Product PDFs

Review this Product

Be the first to review our Human Fas Ligand/TNFSF6 Quantikine ELISA Kit and receive a gift card or discount.